Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Brianne Sullivan

3PUBLICATIONS

10CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical infection agents (incl. prions)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Jul 31, 2023

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: Effects of postoperative fluids beyond the first 24 h.

Yael Berger, Brianne J Sullivan, Eliahu Y Bekhor

|Jul 22, 2021

Lymphocyte-to-monocyte ratio predicts survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Eric Pletcher, Elizabeth Gleeson, Tali Shaltiel

|Feb 20, 2019

A unique presentation of superinfected pseudomyxoma peritonei secondary to a low-grade appendiceal mucinous neoplasm.

Brianne J Sullivan, Nathan Bolton, Umut Sarpel

Pageof 1

Frequent Collaborators

2 joint publications

Natasha Leigh

1 joint publications

Yael Berger

1 joint publications

Eliahu Y Bekhor

1 joint publications

Daniel Solomon

1 joint publications

Eric Pletcher

1 joint publications

Elizabeth Gleeson

1 joint publications

Tali Shaltiel

1 joint publications

Deepa Magge

1 joint publications

Noah Cohen

1 joint publications

Umut Sarpel

Frequent Collaborators

2 joint publications

Natasha Leigh

1 joint publications

Yael Berger

1 joint publications

Eliahu Y Bekhor

1 joint publications

Daniel Solomon

Top Related Videos

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on : Jul 31, 2016

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on : Oct 02, 2015

Culture and Imaging of <em>Ex Vivo</em> Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens

Culture and Imaging of <em>Ex Vivo</em> Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens

Published on : Dec 09, 2022

See more related videos

Top Related Videos

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on : Jul 31, 2016

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on : Oct 02, 2015

Culture and Imaging of <em>Ex Vivo</em> Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens

Culture and Imaging of <em>Ex Vivo</em> Organotypic Pseudomyxoma Peritonei Tumor Slices from Resected Human Tumor Specimens

Published on : Dec 09, 2022

See more related videos